Takayuki Jodai

Association of Probiotic <i>Clostridium butyricum</i> Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer

Yusuke Tomita, Tokunori Ikeda, Shinya Sakata et al. · Cancer Immunology Research · 2020 · 241 citations

Medicine, Immunology, Oncology +15

Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies

Ryo Sato, Kosuke Imamura, Shinya Sakata et al. · Journal of Clinical Medicine · 2019 · 89 citations · Full text

Life Sciences, Immunology, Oncology +17

<i>Clostridium butyricum</i> therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors

Yusuke Tomita, Yoshihiko Goto, Shinya Sakata et al. · OncoImmunology · 2022 · 89 citations · Full text

Life Sciences, Microbiology, Oncology +17

A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti‐PD‐1 immune checkpoint antibody in a lung cancer patient

Takayuki Jodai, Chieko Yoshida, Ryo Sato et al. · Immunity Inflammation and Disease · 2018 · 46 citations · Full text

Medicine, Immunology, Oncology +17

Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations

Yusuke Tomita, Shinya Sakata, Kosuke Imamura et al. · Cancers · 2023 · 31 citations · Full text

Life Sciences, Immunology, Oncology +17